2[6]Weinmann M, Jeremic B, Bamberg M, Bokemeyer C. Treatment of lung cancer in elderly part Ⅱ: small cell lung cancer. Lung Cancer, 2003 Apr, 40(1):1～16
3[7]Kreuzer M, Boffetta P ,Whitley E ,et al Gender differences in lung cancerrisk by smoking : a multicentre casecontrol study in Germany and Italy.British J Cancer ,2000 ,82:227
4[8]Chute JP, Venzon DJ, Hankins L, et al. Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute. Mayo Clin Proc 1997;72:901～12
5[9]Motokura T ,Bloom T , Kim HG ,et al.A novel cyclin encoded by a bcl-1-linked candidate oncogene [J]. Nature ,1991 ,350 (6318) :512
6[10]Reissmann PT , Koga H , Figlin RA , et al Amplification and over-expression of the cyclin D1and epidermal growth factor receptorgenes in nonsmall cell lung cancer. Lung cancer study group.JCancer Res Clin Oncol, 1999 ,125:61～70
7[11]Slebos RJC, Kibbelaar RE, Dalesio O, et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990;323:561-5.
8[12]Klaus Junker Prognostic factors in stage Ⅰ/Ⅱ nonsmall cell lung cancer. Lung Cancer Suppl. 1 (2001)S17～S24
9[13]Korn JA,Filderman AE. Oncogenes and growth factors in human lung cancer. Clin Chest Med, 1993,14:31～41
10[14]Richardson CE, Johnson BE, The biology of lung cancer.[J]Semin Oncol, 1993 ( 20): 105
